Funding round
Encoded Therapeutics Series F
Encoded Therapeutics, which works in gene therapy development in South San Francisco, raised $275M in a Series F round announced on 9 Sep 2026, led by GV, Undisclosed healthcare fund and another healthcare fund. 14 firms took part. It is Encoded Therapeutics' third venture round on record; the one before was a Series D in Jul 2020.
$275M
Amount raised
Not disclosed
Post-money valuation
14
Investors
3 leads
Valuation
What this round says about the price
Encoded Therapeutics did not disclose a valuation in this round. It came 74 months after Encoded Therapeutics' Series D. It is 54% of the $514M Encoded Therapeutics has raised in the venture rounds on record. No later venture round is on record for Encoded Therapeutics.
Investors
Who put money in
GV, Undisclosed healthcare fund and another healthcare fund led the round with 11 other firms.
Lead investors
- GV backs 428 venture-backed companies new investor
- Undisclosed healthcare fund new investor
- another healthcare fund
Also in the round
- ARCH Venture Partners backs 99 venture-backed companies new investor
- backs 8 venture-backed companies new investor
- backs 15 venture-backed companies new investor
- backs 38 venture-backed companies new investor
- Invus backs 83 venture-backed companies new investor
- Janus Henderson Investors new investor
- Matrix Capital Management new investor
- backs 2 venture-backed companies new investor
- backs 17 venture-backed companies new investor
- SoftBank Vision Fund backs 234 venture-backed companies new investor
- Venrock backs 93 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
The closest in time: Series F rounds in any sector within 6 months:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Crusoe Hosting & Cloud Infrastructure Providers | 17 Sep 2026 | $3.90B | $30.90B | Atreides Management and Mubadala Capital |
| Island Tech Companies | 24 Sep 2026 | $400M | $6.40B | Evolution Equity Partners |
| Tabby Payment Processing & Point of Sale | 14 Sep 2026 | $233M | $6.50B | Blue Pool Capital |
| Tech Companies | 13 Oct 2026 | $180M | not disclosed | L Catterton and Partners Group |
| Health Care Services | 14 Aug 2026 | $30M | $387M | not named |
| SambaNova Tech Companies | 8 Jul 2026 | $1.00B | $11.00B | General Atlantic |
| ThreatLocker Tech Companies | 29 Jul 2026 | $190M | $1.60B | Elephant |
| Baseten Software Development Services | 22 Jun 2026 | $1.50B | $13.00B | Altimeter and Conviction |
Sources
Where this comes from
Reported by 7 sources.
Questions
Frequently asked
How much did Encoded Therapeutics raise in its Series F round?
Encoded Therapeutics raised $275M in its Series F round, announced in Sep 2026.
Who led Encoded Therapeutics' Series F round?
GV, Undisclosed healthcare fund and another healthcare fund led it, with ARCH Venture Partners, Braidwell, Farallon, Illumina Ventures and Invus and 6 more.
What was Encoded Therapeutics' valuation at the Series F round?
It was not disclosed.